BiomX Inc. (PHGE): Going concern doubt
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide, the Compliance Plan we submitted to NYSE Regulation on April 24, 2026; ● substantial doubt about our ability to continue as a going concern; ● our ability to raise additional capital on acceptable terms, or at all, including under our existing at-the-market sales agreement, any future at-the-market
Why it matters
A going-concern disclosure reflects substantial doubt about the company's ability to continue operating.